Status: current, Defined. Date: 28-Feb 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3224251000168117 | bupropion hydrochloride 90 mg + naltrexone hydrochloride 8 mg modified release tablet, 112 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3224261000168115 | naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 112 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 112 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 112 | has MPUU | naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Contrave 8/90 (bupropion hydrochloride 90 mg + naltrexone hydrochloride 8 mg) modified release tablet, 112 tablets (trade product pack) | Is a | True | naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 112 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR